The Importance of Nanocarriers' Intra- and Extracellular Degradation: What we Know and Should Know About it?
Curr Med Chem
.
2024;31(2):128-132.
doi: 10.2174/0929867330666230315144546.
Authors
Alessandro Parodi
1
,
Maya V Voronina
1
,
Andrey A Zamyatnin
1
2
3
4
Affiliations
1
Scientific Center for Translation Medicine, Sochi State University, Sochi, 354340, Russia.
2
Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, 119991, Russia.
3
Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
4
Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7X, UK.
PMID:
36924098
DOI:
10.2174/0929867330666230315144546
No abstract available
Keywords:
Nanomedicine; degradation; drug delivery; nanocarrier; proteases; radiosensitization.
Grants and funding
21-75-30020/Russian Science Foundation